Cambium Bio Limited (ASX:CMB)
Australia · Delayed Price · Currency is AUD 0.4100
0.00 (0.00%)
Aug 5, 2026, 11:49 AM AEST
Cambium Bio Market Cap
Cambium Bio has a market cap or net worth of 11.21 million as of August 5, 2026. Its market cap has increased by 44.22% in one year.
Market Cap
11.21M
Enterprise Value
10.85M
Revenue
668.79K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.41
ChartMarket Cap Chart
Since April 5, 2024, Cambium Bio's market cap has increased from 7.97M to 11.21M, an increase of 40.65%. That is a compound annual growth rate of 15.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 11.21M | 3.81% |
| Dec 31, 2025 | 10.80M | 103.21% |
| Dec 31, 2024 | 5.31M | -33.33% |
| Apr 5, 2024 | 7.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Patrys | 22.00M |
| Neurotech International | 21.08M |
| Argenica Therapeutics | 19.91M |
| Ceryvyn Therapeutics | 16.42M |
| ReNerve | 14.65M |
| Immuron | 11.76M |
| AdAlta | 11.24M |
| Bio-Gene Technology | 8.88M |